Rafael Carmena, Director General of the INCLIVA Health Research Institute, and Carlos Rubió, Director General of Laboratorios Rubió, signed a collaboration agreement last June with the aim of promoting research, development, innovation, training, and dissemination in the biomedical field.
Both entities recognize the importance of promoting and strengthening technical, scientific, economic, and educational cooperation. This collaboration is identified as a crucial tool for the development of research in biomedicine and the advancement of the economy.
This agreement represents the joint effort of Laboratorios Rubió and INCLIVA to boost the advancement of biomedical science, from the development of new therapies to education and scientific dissemination.
Both institutions are recognized for their commitment to research and innovation. The agreement between INCLIVA and Laboratorios Rubió will serve to intensify efforts to tackle pending medical challenges and drive significant scientific discoveries in the field of biomedicine.